Columbia Technology Ventures welcomes Wim Sweldens, PhD and
Sam Kongsamut, PhD to the Executives in Residence program
Dear Colleagues,

As many of you may know, CTV’s Executives in Residence (XIR) Program aims to connect Columbia technologies and researchers with seasoned industry executives, venture capitalists, and serial entrepreneurs. By doing so, we hope to leverage the deep domain expertise of these individuals to help accelerate the path of promising Columbia technologies toward market success.
I am excited to welcome two new CTV XIRs: Dr. Wim Sweldens and Dr. Sam Kongsamut.  Wim was most recently the President of Alcatel-Lucent’s Wireless Division, where he led the global development and deployment of LTE 4G technology and oversaw the introduction of the award-winning lightRadio small cell portfolio. Earlier in his role as VP of Network Technology, Wim took the company’s Applications Enablement strategy from paper to practice, allowing service providers to open and leverage their networks for the development of new services and applications. As founder and leader of Alcatel-Lucent Ventures, a strategic new business incubator and investment division inside of Bell Labs, Wim managed the lifecycle - from concept to commercialization - for eight ventures, ranging from enterprise and consumer applications to groundbreaking mobile innovations for operators.
Sam Kongsamut has over 20 years of pharmaceutical R&D and business development experience at Hoechst-Roussel, Aventis, and Sanofi-Aventis. Sam managed various-sized groups of scientists in biochemical pharmacology that served multiple project teams in the neuroscience area, and was a member of the CNS Board that managed the CNS project portfolio. He led or worked on a variety of multi-disciplinary drug discovery and development projects covering a range of technologies and therapeutic indications in neuroscience and aging (OCD, anxiety-depression, schizophrenia, Alzheimer's Disease, Parkinson's Disease, sleep disorders, multiple sclerosis, spinal cord injury, stroke, hearing loss, pain, circadian rhythm disorders, urology, musculoskeletal disorders), including being involved with two marketed drugs that are now helping patients. From 2009-2012, Sam was Director of External Innovation at Sanofi-Aventis, using his experience to identify opportunities for collaboration and licensing for broad therapeutic interests within the Aging Unit.
Wim and Sam join our other current XIRs, Sid Dalal (RAND; Xerox; Bellcore/SAIC/Telcordia) and Jerry Korten (Versamed; GE Healthcare). 
Wim, Sam, Sid and Jerry will be available to Columbia researchers and students for advice and consultation during their 3-month term at Columbia. If you have a project that you think may benefit from their experience and expertise, please reach out to your CTV licensing officer or to to arrange a one-on-one meeting.
We will be adding more XIRs with different backgrounds to the team in the months ahead. For more information, please visit our website at


Orin Herskowitz
Executive Director, CTV
VP for Intellectual Property & Technology Transfer

Columbia innovation

Events & Deadlines

What Happens in Vegas DOESN'T Stay in Vegas: CES Panel Discussion
Date: Wednesday, February 13, 2013
Time: 12:00 PM- 1:00 PM

Private Equity & Venture Capital Conference
Date: Friday, February 15, 2013
Time: 8:00 AM- 6:00 PM

Columbia Entrepreneurship Lecture Series
Speaker: Vishal Misra, Silver Lining
Date: Wednesday, March 20, 2013

Time: 12:00 PM- 1:00 PM

Columbia Innovation

Available Technologies

Genetically engineered cell-based therapy development for cardiac pacemaker rate regulation and cardiac arrhythmia therapy
Click here for more information

Controlled alignment of carbon nanotubes for electrical devices
Click here for more information

Self contained, modular coal gasifier
Click here for more information

 Follow us onTwitter  Tech Ventures Website
How can we help?

Entrepreneur Office Hours
Thinking about launching a new venture and wondering how to get started? Already done it, but looking for specific advice, perspective, or resources? Our experience Venture Lab is here to help.
By Appointment
Click here for more information

Inventor Office Hours
Meet with our dedicated licensing team to discuss the commercial potential of your research and learn about resources to help transform your ideas and inventions into attractive business opportunities.
By appointment
Click here for more information
Columbia Technology Ventures is the technology transfer office of Columbia University.  For questions about our office or events, please visit our website at or send us an e-mail at

Twitter | Facebook | LinkedIn | Technology Ventures Website | Forward to a Friend
© 2012 Columbia University.  You are receiving this email because you have subscribed to the Columbia Technology Ventures mailing list or are a part of the Columbia innovation community.